LLY

959.34

+1.09%↑

NVO

142.62

+0.31%↑

UNH

515.63

+0.71%↑

JNJ

149.09

-0.49%↓

MRK

127.78

+0.31%↑

LLY

959.34

+1.09%↑

NVO

142.62

+0.31%↑

UNH

515.63

+0.71%↑

JNJ

149.09

-0.49%↓

MRK

127.78

+0.31%↑

LLY

959.34

+1.09%↑

NVO

142.62

+0.31%↑

UNH

515.63

+0.71%↑

JNJ

149.09

-0.49%↓

MRK

127.78

+0.31%↑

LLY

959.34

+1.09%↑

NVO

142.62

+0.31%↑

UNH

515.63

+0.71%↑

JNJ

149.09

-0.49%↓

MRK

127.78

+0.31%↑

LLY

959.34

+1.09%↑

NVO

142.62

+0.31%↑

UNH

515.63

+0.71%↑

JNJ

149.09

-0.49%↓

MRK

127.78

+0.31%↑

Search

Boston Scientific Corp.

Suletud

Sektor Tervishoid

77.65 0.92

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

77.57

Max

77.82

Põhinäitajad

By Trading Economics

Sissetulek

-12M

492M

Müük

135M

3.9B

P/E

Sektori keskmine

70.871

23.904

Aktsiakasum

0.56

Kasumimarginaal

12.746

Töötajad

48,000

EBITDA

-27M

981M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+7.17 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

24. juuli 2024

Turustatistika

By TradingEconomics

Turukapital

-1.2B

112B

Eelmine avamishind

76.73

Eelmine sulgemishind

77.65

Uudiste sentiment

By Acuity

57%

43%

301 / 369 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Boston Scientific Corp. Graafik

Seotud uudised

18. juuni 2024, 13:23 UTC

Omandamised, ülevõtmised, äriostud

Correction to Boston Scientific to Buy Silk Road Article

18. juuni 2024, 11:41 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18. juuni 2024, 11:31 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24. apr 2024, 11:01 UTC

Tulu

Boston Scientific Lifts 2024 Outlook After Strong 1Q

4. apr 2024, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information

18. juuni 2024, 20:22 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18. juuni 2024, 14:25 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18. juuni 2024, 12:54 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18. juuni 2024, 11:33 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18. juuni 2024, 11:18 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18. juuni 2024, 11:03 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18. juuni 2024, 11:02 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18. juuni 2024, 11:01 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18. juuni 2024, 11:01 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18. juuni 2024, 11:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24. apr 2024, 12:30 UTC

Peamised uudised
Tulu

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24. apr 2024, 10:36 UTC

Tulu

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24. apr 2024, 10:35 UTC

Tulu

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific Sees 2024 Adj EPS $2.29-Adj EPS $2.34 >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific Sees 2024 EPS $1.43-EPS $1.48 >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific Sees 2Q Adj EPS 57c-Adj EPS 59c >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific Sees 2Q EPS 35c-EPS 37c >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific 1Q Adj EPS 56c >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific 1Q Sales $3.86B >BSX

24. apr 2024, 10:31 UTC

Tulu

Boston Scientific 1Q EPS 33c >BSX

4. apr 2024, 11:25 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Now Sees Mereger Closing in 2H of 2024 >BSX

4. apr 2024, 11:24 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific, Axionics Expect to Promptly Respond to Second Request >BSX

4. apr 2024, 11:24 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific, Axonics Receive Request for Additional Info From FTC Regarding Merger >BSX

31. jaan 2024, 14:19 UTC

Tulu

Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance -- IBD

31. jaan 2024, 12:59 UTC

Tulu

Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts -- IBD

Võrdlus sarnastega

Hinnamuutus

Boston Scientific Corp. Prognoos

Hinnasiht

By TipRanks

7.17% tõus

12 kuu keskmine prognoos

Keskmine 83.26 USD  7.17%

Kõrge 95 USD

Madal 73 USD

Põhineb 22 Wall Streeti analüütiku instrumendi Boston Scientific Corp. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

22 ratings

21

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

76.7 / 77.95Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

301 / 369 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.